Stock Events

Stock Events

Genus 

$31.07
37
-$3.93-11.24% Tuesday 20:00

Statistics

Day High
35
Day Low
35
52W High
37.25
52W Low
30.98
Volume
145
Avg. Volume
14
Mkt Cap
0
P/E Ratio
33.05
Dividend Yield
1.41%
Dividend
0.44

Upcoming

Dividends

1.41%Dividend Yield
Mar 26
$0.15
Dec 25
$0.29
Apr 25
$0.13
Dec 24
$0.28
Mar 24
$0.13
10Y Growth
2.81%
5Y Growth
-0.7%
3Y Growth
3.6%
1Y Growth
6.91%

Earnings

10SepExpected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
33.08
42.03
50.98
59.93
Expected EPS
N/A
Actual EPS
N/A

Financials

2.98%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
883.03MRevenue
26.31MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GENSF. It's not an investment recommendation.
Lloyds Banking Group
9
LLOY.LSE
Spirax Group
9
SPX.LSE
Rio Tinto
8
RIO.LSE
Aviva
8
AV.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zoetis
ZTS
Mkt Cap31.96B
Zoetis is a global animal health company that offers products and services for livestock, which competes directly with Genus's offerings in animal genetics and health.
Elanco Animal Health
ELAN
Mkt Cap12.05B
Elanco Animal Health provides a range of products for animal health and welfare, competing in the same market as Genus, particularly in the livestock sector.
Idexx Laboratories
IDXX
Mkt Cap43.72B
IDEXX Laboratories specializes in diagnostics and healthcare for animals, competing with Genus in the broader animal health market.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories, through its animal health division, competes with Genus in providing products for livestock health and productivity.
Phibro Animal Health
PAHC
Mkt Cap1.53B
Phibro Animal Health Corporation offers animal health and nutritional products for livestock, directly competing with Genus in the animal health sector.
Vir Biotechnology
VIR
Mkt Cap1.83B
Virbac provides veterinary products and services, competing with Genus in the global animal health market, especially in the care and productivity of livestock.
BWX Technologies
BWXT
Mkt Cap14B
BWX Technologies, though primarily focused on nuclear technology, has divisions that could overlap with biotechnological advancements in animal genetics, representing a potential indirect competitor to Genus in innovative animal health solutions.

About

Genus plc is a global animal genetics company, with operations extending across North America, Latin America, the United Kingdom, broader Europe, the Middle East, Russia, Africa, and Asia. The firm organizes its business into three primary segments: Genus PIC, Genus ABS, and Genus Research and Development. Through its PIC brand, the company supplies breeding pigs and boar semen, enabling the production of swine with specific traits for pork processing. Furthermore, under the ABS, Genus, and Bovec labels, it provides bull semen and bovine embryos to facilitate the breeding of calves with targeted characteristics for dairy and beef output. Genus plc also extends specialized technical support to agricultural producers. Established in 1994, the company's headquarters are located in Basingstoke, United Kingdom.
Show more...
CEO
Jorgen Kokke
Employees
3307
Country
United Kingdom
ISIN
GB0002074580
WKN
000762548

Listings

STU
DE
GBE.STU
OTC Link
US
GENSY
F
DE
GBE.F
OTC Link
US
GENSF

0 Comments

Share your thoughts

FAQ

What is Genus stock price today?▼
The current price of GENSF is $31.07 USD — it has decreased by -11.24% in the past 24 hours. Watch Genus stock price performance more closely on the chart.
What is Genus stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Genus stocks are traded under the ticker GENSF.
Is Genus stock price growing?▼
GENSF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Genus has showed a +19.43% increase.
When is the next Genus earnings date?▼
Genus is going to release the next earnings report on September 10, 2026.
What were Genus earnings last quarter?▼
GENSF earnings for the last quarter are 0.81 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Genus revenue for the last year?▼
Genus revenue for the last year amounts to 883.03M USD.
What is Genus net income for the last year?▼
GENSF net income for the last year is 26.31M USD.
Does Genus pay dividends?▼
Yes, GENSF dividends are paid semi-annual. The last dividend per share was 0.15 USD. As of today, Dividend Yield (FWD)% is 1.41%.
How many employees does Genus have?▼
As of September 05, 2026, the company has 3,307 employees.
In which sector is Genus located?▼
Genus operates in the Health & Wellness sector.
When did Genus complete a stock split?▼
Genus has not had any recent stock splits.
Where is Genus headquartered?▼
Genus is headquartered in Basingstoke, United Kingdom.